Protonix - Newsfeeds

Mylan's Generic Version Of Hypertension Drug Nisoldipine Gets FDA Nod
Pantoprazole is a generic version of Wyeth's Protonix DR Tablets. On January 18, the company received FDA nod for the generic version of Bayer's anti-diabetes drug Bayer's Precose, indicated as an adjunct to diet and exercise to improve glycemic control in ...
Cadila Healthcare Ltd Long Term Buy Call: Abhishek Jain, StocksIdea.com
The German multinational is the global patent holder for pantoprazole, a proton pump inhibitor used to treat various gastrointestinal disorders. The company has subsidiaries include Indon Healthcare Limited,
Using clopidogrel, PPIs increases cardiac damage risk: Study
while pantoprazole appeared to be quite safe. Consequently, there is an opportunity for the scientific community to undertake further work on this topic, and perform randomised trials to investigate which PPIs should ...
Buy Sun Pharmaceutical Industries; target of Rs 2111: IIFL
owing to lower profit (due to Caraco issues and lower Protonix profitability) and the expected increase in Caraco’s receivables. Sun has more than USD 650 million in cash and equivalents, and a further USD 130 ...
Jaypee Capital Services neutral on Sun Pharma
Key Risks: 1) Unfavorable ruling in Protonix 2) Acquisition of Taro at a reasonable price. We maintain Neutral with a target price of Rs 1708,” says Jaypee Research report.
pharmiweb.com today archive
Since 2007, Teva has been selling a generic version of Protonix and it was considered an at-risk launch. The original patent on Protonix was held by Nycomed and was licensed to Wyeth, now owned by Pfizer.
I have taken Protonix 40 mg for 7 years - problems
I had always felt bloated and seemed to have dirreaha a lot . I gained a lot of weight while on this medication. I recently read where porlonged use of Protonix could cause medical problems. My pharmacist said get off of ...
TSX Poised For A Positive Open Monday - Canadian Commentary
FDA for a generic of Protonix, or delayed release pantoprazole sodium. In economic news, Statistics Canada said new motor vehicle sales declined 4.7% to 125,792 units in April, falling for a second month.
Protonix ( Pantoprazole) information and side effect
What is Protonix? Protonix decreases the amount of acid produced in the stomach. Protonix is used to treat damage to the esophagus associated with gastroesophageal reflux disease (GERD) and other conditions involving ...
Intellipharmaceutics (IPCI) Files ANDA with U.S. FDA for Generic Protonix
Intellipharmaceutics International Inc. (Nasdaq: IPCI ) today announced that is has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for a generic of Protonix (delayed release ...
Intellipharmaceutics Files ANDA With the FDA for Generic Protonix(R)
TORONTO, June 14, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq: IPCI - News ) (TSX: I - News ) today announced that is has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food ...
Teva Provides Update on Gemzar(R) Litigation
... liability for sales of generic products prior to a final resolution of outstanding patent litigation, including that relating to the generic versions of Neurontin(R), Lotrel(R) and Protonix(R), the extent to which any manufacturing or quality ...
Santarus Inc. Q3 2009 Earnings Call Transcript
I think what we’ve said is we believe that there is typically about a six month period of time where you see introduction of a generic whether that was pantoprazole or generic lansoprazole where it will affect the entire PPI market for about a six ...
Substandard drugs
BANGALORE: The Drugs Testing Laboratory, Bangalore, has declared the following drugs “not of standard quality”: Pantocent-D (Pantoprazole and Domperidone tablets), Batch No. 90230, manufactured by Precision Pharma, Siswan Road, Chanalon; Hexpan-D ...
Teva Reports Third Quarter 2009 Results
... well as continued strong sales of generic versions of Lotrel(R) (amlodipine benazapril), Adderall XR(R) (amphetamine salts), Yasmin(R) (drospirenone and ethinyl estradiol), and Protonix(R) (pantoprazole) launched in previous quarters.
Teva Reports Strong Quarter
The launch of generic versions of Ortho Tri-Cyclen Lo and Eloxatin and continued strong sales from existing products like generic versions of Adderall XR, Yasmin and Protonix helped North America sales grow 34% to $2,164 million. Other products ...
Smokers’ Lung Treatment May Fail to Fire Up Nycomed Bidders
Nycomed needs Daxas to offset sales that the company will lose when patent protection expires for its Pantoprazole heartburn remedy. That medicine is Nycomed’s best-selling product in a portfolio that lacks more promising treatments, said Olav ...
Benefits Of Anti-Clotting Medications Reduced By Common Heartburn ...
Omeprazole correlated with a 39% increased risk of MACE, esomeprazole to a 57% increased risk, pantoprazole to a 61% increased risk and lansoprazole to a 39% increased risk. All of the associations were highly statistically significant. Overall, the ...
Heartburn drugs affect anti-clotting drugs
Omeprazole correlated with a 39 percent increased risk of major adverse cardiovascular events, esomeprazole to a 57 percent increased risk, pantoprazole to a 61 percent increased risk and lansoprazole to a 39 percent increased risk. All of the ...
Refer to a friend
Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: A U.S. multicenter, randomized, double-blind study. American Journal of Gastroenterology 2006; 101:1991-10. Hasselgren G, Lind T, Lundell L et al. Continuous ...

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.


Pages:   1   2   Next

Need A Protonix Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Protonix Case - Submit Your Information Below

Do you need legal assistance with your Protonix case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Protonix Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.